Cargando…

Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma

Background: Although low-grade glioma (LGG) has a good prognosis, it is prone to malignant transformation into high-grade glioma. It has been confirmed that the characteristics of inflammatory factors and immune microenvironment are closely related to the occurrence and development of tumors. It is...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tao, Zuo, Zhifan, Qu, Meilin, Zhou, Yinghui, Li, Qing, Wang, Hongjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545815/
https://www.ncbi.nlm.nih.gov/pubmed/34712139
http://dx.doi.org/10.3389/fphar.2021.748993
_version_ 1784590073950371840
author Han, Tao
Zuo, Zhifan
Qu, Meilin
Zhou, Yinghui
Li, Qing
Wang, Hongjin
author_facet Han, Tao
Zuo, Zhifan
Qu, Meilin
Zhou, Yinghui
Li, Qing
Wang, Hongjin
author_sort Han, Tao
collection PubMed
description Background: Although low-grade glioma (LGG) has a good prognosis, it is prone to malignant transformation into high-grade glioma. It has been confirmed that the characteristics of inflammatory factors and immune microenvironment are closely related to the occurrence and development of tumors. It is necessary to clarify the role of inflammatory genes and immune infiltration in LGG. Methods: We downloaded the transcriptome gene expression data and corresponding clinical data of LGG patients from the TCGA and GTEX databases to screen prognosis-related differentially expressed inflammatory genes with the difference analysis and single-factor Cox regression analysis. The prognostic risk model was constructed by LASSO Cox regression analysis, which enables us to compare the overall survival rate of high- and low-risk groups in the model by Kaplan–Meier analysis and subsequently draw the risk curve and survival status diagram. We analyzed the accuracy of the prediction model via ROC curves and performed GSEA enrichment analysis. The ssGSEA algorithm was used to calculate the score of immune cell infiltration and the activity of immune-related pathways. The CellMiner database was used to study drug sensitivity. Results: In this study, 3 genes (CALCRL, MMP14, and SELL) were selected from 9 prognosis-related differential inflammation genes through LASSO Cox regression analysis to construct a prognostic risk model. Further analysis showed that the risk score was negatively correlated with the prognosis, and the ROC curve showed that the accuracy of the model was better. The age, grade, and risk score can be used as independent prognostic factors (p < 0.001). GSEA analysis confirmed that 6 immune-related pathways were enriched in the high-risk group. We found that the degree of infiltration of 12 immune cell subpopulations and the scores of 13 immune functions and pathways in the high-risk group were significantly increased by applying the ssGSEA method (p < 0.05). Finally, we explored the relationship between the genes in the model and the susceptibility of drugs. Conclusion: This study analyzed the correlation between the inflammation-related risk model and the immune microenvironment. It is expected to provide a reference for the screening of LGG prognostic markers and the evaluation of immune response.
format Online
Article
Text
id pubmed-8545815
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85458152021-10-27 Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma Han, Tao Zuo, Zhifan Qu, Meilin Zhou, Yinghui Li, Qing Wang, Hongjin Front Pharmacol Pharmacology Background: Although low-grade glioma (LGG) has a good prognosis, it is prone to malignant transformation into high-grade glioma. It has been confirmed that the characteristics of inflammatory factors and immune microenvironment are closely related to the occurrence and development of tumors. It is necessary to clarify the role of inflammatory genes and immune infiltration in LGG. Methods: We downloaded the transcriptome gene expression data and corresponding clinical data of LGG patients from the TCGA and GTEX databases to screen prognosis-related differentially expressed inflammatory genes with the difference analysis and single-factor Cox regression analysis. The prognostic risk model was constructed by LASSO Cox regression analysis, which enables us to compare the overall survival rate of high- and low-risk groups in the model by Kaplan–Meier analysis and subsequently draw the risk curve and survival status diagram. We analyzed the accuracy of the prediction model via ROC curves and performed GSEA enrichment analysis. The ssGSEA algorithm was used to calculate the score of immune cell infiltration and the activity of immune-related pathways. The CellMiner database was used to study drug sensitivity. Results: In this study, 3 genes (CALCRL, MMP14, and SELL) were selected from 9 prognosis-related differential inflammation genes through LASSO Cox regression analysis to construct a prognostic risk model. Further analysis showed that the risk score was negatively correlated with the prognosis, and the ROC curve showed that the accuracy of the model was better. The age, grade, and risk score can be used as independent prognostic factors (p < 0.001). GSEA analysis confirmed that 6 immune-related pathways were enriched in the high-risk group. We found that the degree of infiltration of 12 immune cell subpopulations and the scores of 13 immune functions and pathways in the high-risk group were significantly increased by applying the ssGSEA method (p < 0.05). Finally, we explored the relationship between the genes in the model and the susceptibility of drugs. Conclusion: This study analyzed the correlation between the inflammation-related risk model and the immune microenvironment. It is expected to provide a reference for the screening of LGG prognostic markers and the evaluation of immune response. Frontiers Media S.A. 2021-10-12 /pmc/articles/PMC8545815/ /pubmed/34712139 http://dx.doi.org/10.3389/fphar.2021.748993 Text en Copyright © 2021 Han, Zuo, Qu, Zhou, Li and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Han, Tao
Zuo, Zhifan
Qu, Meilin
Zhou, Yinghui
Li, Qing
Wang, Hongjin
Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title_full Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title_fullStr Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title_full_unstemmed Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title_short Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
title_sort comprehensive analysis of inflammatory response–related genes, and prognosis and immune infiltration in patients with low-grade glioma
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545815/
https://www.ncbi.nlm.nih.gov/pubmed/34712139
http://dx.doi.org/10.3389/fphar.2021.748993
work_keys_str_mv AT hantao comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma
AT zuozhifan comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma
AT qumeilin comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma
AT zhouyinghui comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma
AT liqing comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma
AT wanghongjin comprehensiveanalysisofinflammatoryresponserelatedgenesandprognosisandimmuneinfiltrationinpatientswithlowgradeglioma